OBJECTIVES: To analyze the influence of compression on tissue integration and degradation of soft tissue substitutes. MATERIAL AND METHODS: Six subcutaneous pouches in twenty-eight rats were prepared and boxes made of Al2O3 were implanted and used as carriers for soft tissue substitutes: a collagen matrix (MG), two volume-stable collagen matrices (FG/MGA), and a polycaprolactone scaffold(E). The volume-stable materials (FG/MGA/E) were further implanted with a twofold (2) and a fourfold (4) compression, created by the stacking of additional layers of the substitute materials. The samples were retrieved at 1, 2, and 12 weeks (10 groups, 3 time points, n = 5 per time point and group, overall, 150 samples). The area fraction of infiltrated fibroblasts and inflammatory cells was evaluated histologically. Due to within-subject comparisons, mixed models were conducted for the primary outcome. The level of significance was set at 5%. RESULTS: The area fraction of fibroblasts increased in all groups over time. At 12 weeks, the densely compressed materials FG4 (1.1%), MGA4 (1.7%), and MGA2 (2.5%) obtained lower values as compared to the other groups, ranging between 4.7 (E2) and 6.5% (MG). Statistically significant differences (p ≤ 0.05) were observed between groups FG4 vs MG/FG2/E/E4 as well as between MGA4 vs MG/FG2/E/E4 and E vs MGA2. CONCLUSIONS: Higher levels of compression led to delayed tissue integration. The effect of different compression levels was more distinct when compared to the differences between the materials. CLINICAL RELEVANCE: All biomaterials demonstrated tissue integration and a minimal concomitant inflammatory reaction. Clinically, it might be more favorable to obtain a sufficient flap release or to reduce the material size to improve the tissue integration processes.
OBJECTIVES: To analyze the influence of compression on tissue integration and degradation of soft tissue substitutes. MATERIAL AND METHODS: Six subcutaneous pouches in twenty-eight rats were prepared and boxes made of Al2O3 were implanted and used as carriers for soft tissue substitutes: a collagen matrix (MG), two volume-stable collagen matrices (FG/MGA), and a polycaprolactone scaffold(E). The volume-stable materials (FG/MGA/E) were further implanted with a twofold (2) and a fourfold (4) compression, created by the stacking of additional layers of the substitute materials. The samples were retrieved at 1, 2, and 12 weeks (10 groups, 3 time points, n = 5 per time point and group, overall, 150 samples). The area fraction of infiltrated fibroblasts and inflammatory cells was evaluated histologically. Due to within-subject comparisons, mixed models were conducted for the primary outcome. The level of significance was set at 5%. RESULTS: The area fraction of fibroblasts increased in all groups over time. At 12 weeks, the densely compressed materials FG4 (1.1%), MGA4 (1.7%), and MGA2 (2.5%) obtained lower values as compared to the other groups, ranging between 4.7 (E2) and 6.5% (MG). Statistically significant differences (p ≤ 0.05) were observed between groups FG4 vs MG/FG2/E/E4 as well as between MGA4 vs MG/FG2/E/E4 and E vs MGA2. CONCLUSIONS: Higher levels of compression led to delayed tissue integration. The effect of different compression levels was more distinct when compared to the differences between the materials. CLINICAL RELEVANCE: All biomaterials demonstrated tissue integration and a minimal concomitant inflammatory reaction. Clinically, it might be more favorable to obtain a sufficient flap release or to reduce the material size to improve the tissue integration processes.
Authors: Christian M Schmitt; Tobias Moest; Rainer Lutz; Falk Wehrhan; Friedrich W Neukam; Karl Andreas Schlegel Journal: Clin Oral Implants Res Date: 2015-02-27 Impact factor: 5.977
Authors: Dimitris N Tatakis; Leandro Chambrone; Edward P Allen; Burton Langer; Michael K McGuire; Christopher R Richardson; Ion Zabalegui; Homayoun H Zadeh Journal: J Periodontol Date: 2014-10-15 Impact factor: 6.993
Authors: Daniel S Thoma; Marco Zeltner; Monika Hilbe; Christoph H F Hämmerle; Jürg Hüsler; Ronald E Jung Journal: J Clin Periodontol Date: 2016-08-12 Impact factor: 8.728
Authors: Daniel S Thoma; Borvornwut Buranawat; Christoph H F Hämmerle; Ulrike Held; Ronald E Jung Journal: J Clin Periodontol Date: 2014-04 Impact factor: 8.728
Authors: Maurizio S Tonetti; Pierpaolo Cortellini; Gaia Pellegrini; Michele Nieri; Daniele Bonaccini; Mario Allegri; Philippe Bouchard; Francesco Cairo; Gianpaolo Conforti; Ioannis Fourmousis; Filippo Graziani; Adrian Guerrero; Jan Halben; Jacques Malet; Giulio Rasperini; Heinz Topoll; Hannes Wachtel; Beat Wallkamm; Ion Zabalegui; Otto Zuhr Journal: J Clin Periodontol Date: 2017-11-21 Impact factor: 8.728